Skip to main content
Novartis
language-selector-globe
Choose location
language-selector-globe Canada |
EnglishFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe
Choose location
language-selector-globeCanada
EnglishFrançais
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Canada 
        • Novartis Biome in Canada 
      • Diversity, Equity and Inclusion 
      • Executive Committee 
      • People and Culture 
      • Therapeutic Areas 
      • Products 
      • Our people Stories 
      • Contact Us 
      Woman and man looking at laptop
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Patient perspective Stories 
      • Grants and Donations 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • HCP Portal 
      • Products 
      • Pipeline (EN) 
      • Adverse Event Reporting 
      • Clinical Trials 
      • Novartis Clinical Trials 
      • Disclosure Of Payments To Healthcare Professionals 
      Healthcare Professionals Header Image
      Healthcare Professionals
    • ESG 
      • Access 
      • Ethics, Risk and Compliance 
      • Grants and Donations 
      • Health Equity Initiative 
        • Guidelines and Eligibility Criteria 
        • About the Novartis Health Equity Initiative 
        • Past Winners 
        • Online Application 
      • Corporate Responsibility 
        • AODA Compliant - EN (PDF 0.2 MB) 
        • AODA Compliant - FR (PDF 0.2 MB) 
        • AMA Compliant - EN (PDF 0.2 MB) 
        • AMA Compliant - FR (PDF 0.2 MB)  
        • Disclosure Of Payments To Healthcare Professionals 
        • Environmental Sustainability 
      • Reporting and Transparency Hub 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Our people Stories 
      • Website Privacy Policy 
      • General Privacy Notice for Business Partners 
      • General Privacy Notice for Third Parties 
      • General Privacy Notice for External Stakeholders 
      • Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints " 
    • Careers 
      • Diversity, Equity and Inclusion 
      • People and Culture 
      • Career Search 
      • How We Work 
      • Well-being 
      Two women chatting
      Careers
    • Contact Us 
Header
Environment, Society and Governance

Environment, Society and Governance

As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
Ethical Behaviour header

Ethical Behaviour

At Novartis, we hold ourselves to high ethical standards and do not tolerate unethical behavior.

Grants & Donations

Grants and Donations

Novartis Canada is deeply committed to providing support to organizations that deliver real benefits to our communities and beyond.

People seating outside

Corporate Responsibility

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues.

Health Equity in Canada

Novartis Health Equity Initiative

A $500,000 CAD fund to help promote equal access to healthcare in Canada. We invite all eligible organizations to apply for funding.

Novartis Canada

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis Websites
  • Global site
  • HCP Portal
Footer Bottom
© 2025 Novartis AG
  • Terms of Use
  • Privacy
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Canada.